Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Praticò

Showing results (11-20 of 199) with videos related to

Pageof 20
Sort By:
The American Journal of Pathology|March 26, 2011
Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer's disease transgenic mouse model involvement of γ-secretaseJin Chu, Domenico Praticò
Scientific Reports|December 8, 2017
Effect of canola oil consumption on memory, synapse and neuropathology in the triple transgenic mouse model of Alzheimer's diseaseElisabetta Lauretti, Domenico Praticò
Neurobiology of Aging|January 23, 2017
The retromer complex system in a transgenic mouse model of AD: influence of ageJin Chu, Domenico Praticò
Journal of Alzheimer'S Disease : JAD|May 16, 2018
Novel Key Players in the Development of Tau Neuropathology: Focus on the 5-LipoxygenaseElisabetta Lauretti, Domenico Praticò
Annals of Neurology|February 1, 2011
5-lipoxygenase as an endogenous modulator of amyloid β formation in vivoJin Chu, Domenico Praticò
Brain Research Bulletin|March 24, 2016
The 5-Lipoxygenase as modulator of Alzheimer's γ-secretase and therapeutic targetJin Chu, Domenico Praticò
Annals of Neurology|January 13, 2006
Coxibs and Alzheimer's disease: should they stay or should they go?Omidreza Firuzi, Domenico Praticò
Cardiovascular Psychiatry and Neurology|November 26, 2009
The 5-lipoxygenase as a common pathway for pathological brain and vascular agingJin Chu, Domenico Praticò
Neurobiology of Aging|January 22, 2013
5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5Jin Chu, Domenico Praticò
Annals of Neurology|February 6, 2021
Endosome Dysregulation in Down Syndrome: A Potential Contributor to Alzheimer Disease PathologyAlessia Filippone, Domenico Praticò
Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:
Pageof 20
The American Journal of Pathology|March 26, 2011
Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer's disease transgenic mouse model involvement of γ-secretaseJin Chu, Domenico Praticò
Scientific Reports|December 8, 2017
Effect of canola oil consumption on memory, synapse and neuropathology in the triple transgenic mouse model of Alzheimer's diseaseElisabetta Lauretti, Domenico Praticò
Neurobiology of Aging|January 23, 2017
The retromer complex system in a transgenic mouse model of AD: influence of ageJin Chu, Domenico Praticò
Journal of Alzheimer'S Disease : JAD|May 16, 2018
Novel Key Players in the Development of Tau Neuropathology: Focus on the 5-LipoxygenaseElisabetta Lauretti, Domenico Praticò
Annals of Neurology|February 1, 2011
5-lipoxygenase as an endogenous modulator of amyloid β formation in vivoJin Chu, Domenico Praticò
Brain Research Bulletin|March 24, 2016
The 5-Lipoxygenase as modulator of Alzheimer's γ-secretase and therapeutic targetJin Chu, Domenico Praticò
Annals of Neurology|January 13, 2006
Coxibs and Alzheimer's disease: should they stay or should they go?Omidreza Firuzi, Domenico Praticò
Cardiovascular Psychiatry and Neurology|November 26, 2009
The 5-lipoxygenase as a common pathway for pathological brain and vascular agingJin Chu, Domenico Praticò
Neurobiology of Aging|January 22, 2013
5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5Jin Chu, Domenico Praticò
Annals of Neurology|February 6, 2021
Endosome Dysregulation in Down Syndrome: A Potential Contributor to Alzheimer Disease PathologyAlessia Filippone, Domenico Praticò
Pageof 20